FORMAN ERIC (Secretary) purchased 4.0% of their position (3.94K shares) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. on the open market
Open‑market purchase worth $2.2K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/23/2022ACC: 0001493152-22-033573
Officer· Secretary
Since Dec 2020
+3.94K
Net shares
Net buyer
$2.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
3.94K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.46K
Price / share
$0.56
Trade value
$815.92
% of position
1.5%
11/21/2022
98.14K→99.60K
Common Stock
Indirect
Shares
+2.48K
Price / share
$0.56
Trade value
$1.39K
% of position
2.5%
11/22/2022
99.60K→102.08K
Total
Net shares
+3.94K
Net value
$2.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/21/2022 | P · Purchase | +1.46K | $0.56 | $815.92 | 1.5% | 98.14K | 99.60K |
| Common Stock Indirect | 11/22/2022 | P · Purchase | +2.48K | $0.56 | $1.39K | 2.5% | 99.60K | 102.08K |
| Total | +3.94K | $2.21K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned38.60K
Total
38.60K direct38.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 38.60K | Direct |
| Total | 38.60K | 38.60K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported